The goal of this study is to assess the safety and efficacy of JGT (Jaeumgeonbi-Tang). A randomized, double-blind, parallel-group, placebo-controlled clinical trial was conducted and changes in symptoms and quality of life of the patients were evaluated.
This study's protocol was designed to assess the efficacy of JGT (Jaeumgeonbi-Tang) for chronic subjective dizziness. * This design of the study is a randomized, double-blind, parallel-group, placebo-controlled design. * Symptoms and quality of life of chronic subjective dizziness patients will be evaluated. * Dizziness severity and quality of life of the patients will be evaluated using DHI (Dizziness Handicap Inventory) (1) before treatment (baseline), (2) after 2 weeks, and (3) after 4 weeks of JGT treatment. * Blood samples of the patients will be gathered before and after JGT treatment for pathophysiological analysis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
50
JGT tablet (composed of 19 herbs), 24 g daily (single dose=8 g), t.i.d. for 28 days
Corn starch tablet, 24 g daily (single dose=8 g), t.i.d. for 28 days
Daejeon Korean Medicine Hospital of Daejeon Unversity
Daejeon, South Korea
Dizziness handicap Inventory
The DHI (Dizziness Handicap Inventory) is a 25-item self-report questionnaire that quantifies the effect of dizziness on daily life by measuring the self-perceived handicap of the patients.
Time frame: Change from Baseline DHI score at 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.